首页 › 基金 › Palo Alto Investors LP › URGN

Palo Alto Investors LP 对 URGN 的持仓历史

UROGEN PHARMA LTD · 医疗保健

Palo Alto Investors LP 在 Q3 2026 的 13F 申报中披露持有 URGN(UROGEN PHARMA LTD)24,500 股,市值约 US$995K,约占其申报组合的 0.15%,在其申报持仓中市值排名第 49 位。 Palo Alto Investors LP 最近 13 个申报季度中有 13 个季度披露了 URGN 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)24.50K 股
申报持仓市值$995.43K
组合权重0.15%
首次申报Q3 2023
最近变动持有
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Palo Alto Investors LP 对 URGN 的持仓演变

Palo Alto Investors LP 于 Q3 2023 首次披露 URGN 持仓:24,500 股(约 US$343K)。 该持仓在 Q3 2026 达到峰值 24,500 股,市值约 US$995K。 在 13 次申报中,Palo Alto Investors LP 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 24,500 股、市值约 US$995K。

逐季持仓明细

季度股数金额变化
Q3 2023 24.50K $343.25K 新进
Q4 2023 24.50K $367.50K 持有
Q1 2024 24.50K $367.50K 持有
Q2 2024 24.50K $411.11K 持有
Q3 2024 24.50K $311.15K 持有
Q4 2024 24.50K $260.93K 持有
Q1 2025 24.50K $270.97K 持有
Q2 2025 24.50K $335.65K 持有
Q3 2025 24.50K $488.77K 持有
Q4 2025 24.50K $573.79K 持有
Q1 2026 24.50K $440.51K 持有
Q2 2026 24.50K $901.60K 持有
Q3 2026 24.50K $995.43K 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 URGN 与 13F 数据

URGN(UROGEN PHARMA LTD)属于医疗保健行业。我们追踪的基金中还有 49 只申报持有 URGN,申报仓位最大的包括:RTW INVESTMENTS, LP (US$184.6M), Kynam Capital Management, LP (US$98.9M), Jefferies Financial Group Inc. (US$89.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 URGN 的基金

查看 URGN 的全部基金持有人 →

常见问题

How long has Palo Alto Investors LP held URGN?

Palo Alto Investors LP has disclosed URGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Palo Alto Investors LP's current position in URGN?

As of Q3 2026, Palo Alto Investors LP holds 24.50K shares of URGN (UROGEN PHARMA LTD), valued at $995.43K, representing 0.15% of its reported portfolio and ranking #49.

Has Palo Alto Investors LP been buying or selling URGN?

In the latest 13F filing (Q3 2026), Palo Alto Investors LP held unchanged its position in URGN. The position peaked in Q3 2026 at 24.50K shares.

Which other funds hold URGN?

Other major institutional holders of URGN include RTW INVESTMENTS, LP, Kynam Capital Management, LP, Jefferies Financial Group Inc., among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.